<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">nefr-131</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Прогнозирование риска развития кардиоваскулярной кальцификации у пациентов, получающих хронический гемодиализ</article-title><trans-title-group xml:lang="en"><trans-title>Cardio-vascular oalcification risk prognosis in patients receiving chronic hemodialysis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Руденко</surname><given-names>Л. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Rudenko</surname><given-names>L. I.</given-names></name></name-alternatives><email xlink:type="simple">rudenko.liliya@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Батюшин</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Batiushin</surname><given-names>M. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кастанаян</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kastanayan</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воробьев</surname><given-names>Б. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Vorobiev</surname><given-names>B. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ростовский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>01</day><month>09</month><year>2015</year></pub-date><volume>19</volume><issue>5</issue><fpage>72</fpage><lpage>76</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Руденко Л.И., Батюшин М.М., Кастанаян А.А., Воробьев Б.И., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Руденко Л.И., Батюшин М.М., Кастанаян А.А., Воробьев Б.И.</copyright-holder><copyright-holder xml:lang="en">Rudenko L.I., Batiushin M.M., Kastanayan A.A., Vorobiev B.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/131">https://journal.nephrolog.ru/jour/article/view/131</self-uri><abstract><p>ЦЕЛЬ ИССЛЕДОВАНИЯ: выявить факторы развития кардиоваскулярной кальцификации, определить взаимосвязь между выраженностью клапанной и сосудистой кальцификацией при ХБП С5д стадии. ПАЦИЕНТЫ И МЕТОДЫ: в исследовании были включены 83 пациента из двух центров амбулаторного гемодиализа. У всех изучали анамнестические, антропометрические, лабораторные данные; анализировали результаты инструментальных методов исследования, включая эхокардиографическое исследование сердца и обзорную рентгенограмму брюшной полости в боковой проекции. РЕЗУЛЬТАТЫ. Выявлена положительная корреляционная взаимосвязь между выраженностью кальцификации клапанов сердца, оцененной по данным эхокардиографии, и степенью кальцификации аорты по данным обзорной рентгенографии брюшной полости (r=0,301, р=0,006). Выявлена роль недостаточности питания и воспаления в развитии внеоссальной кальцификации. При снижении в сыворотке крови уровня общего белка (χ2=8,97, р=0,003), альбумина (χ2=13,9, р&lt;0,01), а также пульсового артериального давления (χ2=5,9, р=0,01) возрастает вероятность формирования кардиоваскулярной кальцификации. Увеличение риска развития кальцификации происходит не только по мере возрастания пульсового артериального давления, но и при развитии артериальной гипертензии (χ2=10,6, р=0,005). ЗАКЛЮЧЕНИЕ. Таким образом, выраженность клапанной кальцификации ассоциируется с кальцификацией аорты, установлена роль недостаточности питания, воспаления и нарушения кальций-фосфорного гомеостаза в развитии внеоссальной кальцификации.</p></abstract><trans-abstract xml:lang="en"><p>THE AIM: to identify risk factors of cardiovascular calcification and to determine relationship between severity of valvular and vascular calcification in patients with S5d CKD. PATIENTS AND METHODS: The study involved 83 patients of two outpatient hemodialysis centers. In all patients studied medical history, anthropometric and laboratory data. We analyzed results of instrumental methods, including heart echocardiography and abdominal plain film in the lateral projection. RESULTS: Positive correlation between severity of heart valve calcification as assessed by echocardiography, and degree of aortic calcification according to survey abdominal radiography (r = 0,301, p = 0,006). Revealed malnutrition and inflammation importance in extraossal calcification development. At lower total protein (χ2=8,97, р=0,003), lower level of albumin (χ2=13,9, р&lt;0,01) and increasing of pulse blood pressure (χ2=5,9, р=0,01) cardiovascular calcification formation possibility increased. calcification risk increase occurs not only with pulse pressure increase, but also in hypertension development (χ2=10,6, р=0,005). CONCLUSION: Thus, the severity of valvular calcification associated with aorta calcification, role of malnutrition, inflammation and calcium-phosphorus homeostasis disorders in extraossal calcification development is established.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая болезнь почек</kwd><kwd>внеоссальная кальцификация</kwd><kwd>хронический гемодиализ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic kidney disease</kwd><kwd>extraossal calcification</kwd><kwd>chronic hemodialysis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">London G, Guerin A, Marchais S et al. Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740</mixed-citation><mixed-citation xml:lang="en">London G, Guerin A, Marchais S et al. Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Батюшин ММ, Галушкин АА, Руденко ЛИ и др. Особенности течения хронической почечной недостаточности, осложненной вторичным гиперпаратиреозом. Мед вестн Юга России 2012; 1: 74-76. [Batiushin MM, Galushkin AA, Rudenko LI et al. Features of chronic renal failure complicated by secondary hyperparathyroidism. Medicinskij vestnik Juga Rossii 2012; 1: 74-76]</mixed-citation><mixed-citation xml:lang="en">Батюшин ММ, Галушкин АА, Руденко ЛИ и др. Особенности течения хронической почечной недостаточности, осложненной вторичным гиперпаратиреозом. Мед вестн Юга России 2012; 1: 74-76. [Batiushin MM, Galushkin AA, Rudenko LI et al. Features of chronic renal failure complicated by secondary hyperparathyroidism. Medicinskij vestnik Juga Rossii 2012; 1: 74-76]</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Волков ММ. Биохимические показатели фосфорнокальциевого обмена у пациентов с хронической болезнью почек 1-5 стадий. Нефрология 2009; 13(3):49-51 [Volkov MM. Biohimicheskie pokazateli fosforno-kal’cievogo obmena u pacientov s hronicheskoj bolezn’ju pochek 1-5 stadij. Nefrologija 2009; 13(3):49-51]</mixed-citation><mixed-citation xml:lang="en">Волков ММ. Биохимические показатели фосфорнокальциевого обмена у пациентов с хронической болезнью почек 1-5 стадий. Нефрология 2009; 13(3):49-51 [Volkov MM. Biohimicheskie pokazateli fosforno-kal’cievogo obmena u pacientov s hronicheskoj bolezn’ju pochek 1-5 stadij. Nefrologija 2009; 13(3):49-51]</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Волков ММ, Гордеева Л.А., Смирнов А.В. Кальциноз брюшной аорты у пациентов с хронической болезнью почек. Нефрология 2009; 13(3):39-41 [Volkov MM, Gordeeva LA, Smirnov AV. Kal’cinoz brjushnoj aorty u pacientov s hronicheskoj bolezn’ju pochek. Nefrologija 2009; 13(3):39-41]</mixed-citation><mixed-citation xml:lang="en">Волков ММ, Гордеева Л.А., Смирнов А.В. Кальциноз брюшной аорты у пациентов с хронической болезнью почек. Нефрология 2009; 13(3):39-41 [Volkov MM, Gordeeva LA, Smirnov AV. Kal’cinoz brjushnoj aorty u pacientov s hronicheskoj bolezn’ju pochek. Nefrologija 2009; 13(3):39-41]</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Рафрафи Х, Румянцев АШ. Статус витамина D и состояние сердечно-сосудистой системы у пациентов с хронической болезнью почек С5д стадии. Нефрология 2015; 19(4): 51-54 [Rafrafi H, Rumjancev ASh. Status vitamina D i sostojanie serdechno-sosudistoj sistemy u pacientov s hronicheskoj bolezn’ju pochek S5d stadii. Nefrologija 2015; 19(4): 51-54]</mixed-citation><mixed-citation xml:lang="en">Рафрафи Х, Румянцев АШ. Статус витамина D и состояние сердечно-сосудистой системы у пациентов с хронической болезнью почек С5д стадии. Нефрология 2015; 19(4): 51-54 [Rafrafi H, Rumjancev ASh. Status vitamina D i sostojanie serdechno-sosudistoj sistemy u pacientov s hronicheskoj bolezn’ju pochek S5d stadii. Nefrologija 2015; 19(4): 51-54]</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Li X, Yang H, Giachelli C. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 2006; 98: 905-912</mixed-citation><mixed-citation xml:lang="en">Li X, Yang H, Giachelli C. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 2006; 98: 905-912</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Massy ZA, Mentaverri R, Mozar A et al. The pathophysiology of vascular calcification: are osteoclast-like cells the missing link? Diabetes Metab 2008; 34: 16-20</mixed-citation><mixed-citation xml:lang="en">Massy ZA, Mentaverri R, Mozar A et al. The pathophysiology of vascular calcification: are osteoclast-like cells the missing link? Diabetes Metab 2008; 34: 16-20</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Nancollas GH, LoRe M, Perez L et al. Mineral phases of calcium phosphate. Anat Rec 1989; 224: 234-241</mixed-citation><mixed-citation xml:lang="en">Nancollas GH, LoRe M, Perez L et al. Mineral phases of calcium phosphate. Anat Rec 1989; 224: 234-241</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Heiss A, Pipich V, Jahnen-Dechent W et al. Fetuin-A is a mineral carrier protein: small angle neutron scattering provides new insight on fetuin-a controlled calcification inhibition. Biophys J 2010; 99: 3986-3995</mixed-citation><mixed-citation xml:lang="en">Heiss A, Pipich V, Jahnen-Dechent W et al. Fetuin-A is a mineral carrier protein: small angle neutron scattering provides new insight on fetuin-a controlled calcification inhibition. Biophys J 2010; 99: 3986-3995</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hunt J, Fairman R, Mitchell M et al. Bone formation in carotid plaques: a clinicopathological study. Stroke 2002; 33: 1214-1219</mixed-citation><mixed-citation xml:lang="en">Hunt J, Fairman R, Mitchell M et al. Bone formation in carotid plaques: a clinicopathological study. Stroke 2002; 33: 1214-1219</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Honkanen E, Kauppila L, Wikström B et al. Abdominal aortic calcification in dialysis patients: results of the CORD study. Nephrol Dial Transplant 2008; 23(12): 4009-4015</mixed-citation><mixed-citation xml:lang="en">Honkanen E, Kauppila L, Wikström B et al. Abdominal aortic calcification in dialysis patients: results of the CORD study. Nephrol Dial Transplant 2008; 23(12): 4009-4015</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Wang AY, Woo J, Wang M et al. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant 2005; 20(2): 396-403</mixed-citation><mixed-citation xml:lang="en">Wang AY, Woo J, Wang M et al. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant 2005; 20(2): 396-403</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Nair CK, Aronow WS, Sketch MH et al. Correlation between calcific aortic stenosis diagnosed by two-dimensional echocardiography and cardiac catheterization. Clin Cardiol 1984; 7: 280-282</mixed-citation><mixed-citation xml:lang="en">Nair CK, Aronow WS, Sketch MH et al. Correlation between calcific aortic stenosis diagnosed by two-dimensional echocardiography and cardiac catheterization. Clin Cardiol 1984; 7: 280-282</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Aronow WS, Ahn C, Kronzon I. Association of mitral annular calcium with symptomatic peripheral arterial disease in older persons. Am J Cardiol 2001; 88(3): 333-334</mixed-citation><mixed-citation xml:lang="en">Aronow WS, Ahn C, Kronzon I. Association of mitral annular calcium with symptomatic peripheral arterial disease in older persons. Am J Cardiol 2001; 88(3): 333-334</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Blacher J, Guerin AP, Pannier B et al. Arterial calcifica tions, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38(4): 938-942</mixed-citation><mixed-citation xml:lang="en">Blacher J, Guerin AP, Pannier B et al. Arterial calcifica tions, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38(4): 938-942</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Бестаева ТЛ, Дзгоева ФУ, Сопоев МЮ. Фактор роста фибробластов и остеопротегерин в развитии кардиоваскулярных осложнений при хронической болезни почек. Клин мед Казахстана 2014; 1 (1): 108-110. [Bestaeva TL, Dzgoeva FU, Sopoev MJu. The fibroblast growth factor and osteoprotegerin in the development of cardiovascular complications in chronic kidney disease. Klinicheskaja Medicina Kazahstana 2014; 1 (1): 108-110]</mixed-citation><mixed-citation xml:lang="en">Бестаева ТЛ, Дзгоева ФУ, Сопоев МЮ. Фактор роста фибробластов и остеопротегерин в развитии кардиоваскулярных осложнений при хронической болезни почек. Клин мед Казахстана 2014; 1 (1): 108-110. [Bestaeva TL, Dzgoeva FU, Sopoev MJu. The fibroblast growth factor and osteoprotegerin in the development of cardiovascular complications in chronic kidney disease. Klinicheskaja Medicina Kazahstana 2014; 1 (1): 108-110]</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Giachelli C. The emerging role of phosphate in vascular calcification. Kidney Int 2009; 75: 890-897</mixed-citation><mixed-citation xml:lang="en">Giachelli C. The emerging role of phosphate in vascular calcification. Kidney Int 2009; 75: 890-897</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Pedrinelli R, Dell’Omo G, Penno G et al. Microalbuminuria and pulse pressure in hypertensive and atherosclerotic men. Hypertension 2000; 35: 48-54</mixed-citation><mixed-citation xml:lang="en">Pedrinelli R, Dell’Omo G, Penno G et al. Microalbuminuria and pulse pressure in hypertensive and atherosclerotic men. Hypertension 2000; 35: 48-54</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">An WS, Son YK. Vascular calcification on plain radiographs is associated with carotid intima media thickness, malnutrition and cardiovascular events in dialysis patients: a prospective observational study. BMC Nephrol 2013; 29: 14</mixed-citation><mixed-citation xml:lang="en">An WS, Son YK. Vascular calcification on plain radiographs is associated with carotid intima media thickness, malnutrition and cardiovascular events in dialysis patients: a prospective observational study. BMC Nephrol 2013; 29: 14</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lim LM, Kuo HT, Kuo MC et al. Low serum calcium is associated with poor renal outcomes in chronic kidney disease stages 3-4 patients. BMC Nephrol 2014; 21: 15-23</mixed-citation><mixed-citation xml:lang="en">Lim LM, Kuo HT, Kuo MC et al. Low serum calcium is associated with poor renal outcomes in chronic kidney disease stages 3-4 patients. BMC Nephrol 2014; 21: 15-23</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Srivaths PR, Goldstein SL, Silverstein DM et al. Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients. Pediatr Nephrol 2011; 26(6): 945-951</mixed-citation><mixed-citation xml:lang="en">Srivaths PR, Goldstein SL, Silverstein DM et al. Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients. Pediatr Nephrol 2011; 26(6): 945-951</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ohara T, Hashimoto Y, Matsumura A et al. Accelerated progression and morbidity in patients with aortic stenosis on chronic dialysis. Circ J 2005; 69(12): 1535-1539</mixed-citation><mixed-citation xml:lang="en">Ohara T, Hashimoto Y, Matsumura A et al. Accelerated progression and morbidity in patients with aortic stenosis on chronic dialysis. Circ J 2005; 69(12): 1535-1539</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Egbuna OI, Taylor JG, Bushinsky DA et al. Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure. Clin Transplant 2007; 21(4): 558-566</mixed-citation><mixed-citation xml:lang="en">Egbuna OI, Taylor JG, Bushinsky DA et al. Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure. Clin Transplant 2007; 21(4): 558-566</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Hjortnaes J, Butcher J, Figueiredo JL et al. Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation. Eur Heart J 2010; 31(16): 1975-1984</mixed-citation><mixed-citation xml:lang="en">Hjortnaes J, Butcher J, Figueiredo JL et al. Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation. Eur Heart J 2010; 31(16): 1975-1984</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
